High Purity 142217 -69-4 Entecavir Hepavital

نموذج رقم.
142217-69-4
العلامة التجارية
blue lake
الأصل
Jiangxi China
القدرة الإنتاجية
60 Tons Per Month
السعر المرجعي
$ 90.00 - 9,000.00
اتصل بنا

وصف المنتجات



Company contact information:



Drug Description:


Entecavir is a prescription medication that is used to treat chronic hepatitis B virus (HBV) infection. It belongs to a class of drugs called nucleoside analogs, which work by blocking the replication of the virus.

Entecavir is taken orally, typically once a day, and is available in tablet form. It is important to take the medication as directed by your healthcare provider, and to not stop taking it without consulting your doctor.

Entecavir is generally well-tolerated, but like all medications, it may cause side effects in some people. The most common side effects of entecavir include headache, fatigue, dizziness, and nausea. In rare cases, it may cause more serious side effects such as liver damage.

If you are prescribed entecavir, it is important to have regular blood tests to monitor your liver function and to ensure that the medication is working properly. Your healthcare provider will also monitor you for any potential side effects and adjust your treatment plan as needed.

High Purity 142217-69-4 Entecavir Hepavital

Property NameProperty ValueReference
Molecular Weight277.28Computed by PubChem 2.1 (PubChem release 2023.05.07)
XLogP3-AA-1.3Computed by XLogP3 3.0 (PubChem release 2023.05.07)
Hydrogen Bond Donor Count4Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Hydrogen Bond Acceptor Count5Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Rotatable Bond Count2Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Exact Mass277.11748936Computed by PubChem 2.1 (PubChem release 2023.05.07)
Monoisotopic Mass277.11748936Computed by PubChem 2.1 (PubChem release 2023.05.07)
Heavy Atom Count20Computed by PubChem
Complexity480Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Isotope Atom Count0Computed by PubChem
Defined Atom Stereocenter Count3Computed by PubChem
Undefined Atom Stereocenter Count0Computed by PubChem
Defined Bond Stereocenter Count0Computed by PubChem
Undefined Bond Stereocenter Count0Computed by PubChem
Covalently-Bonded Unit Count1Computed by PubChem
Compound Is CanonicalizedYesComputed by PubChem (release 2023.05.07)

{\displaystyle {\ce {4C6H5C(O)CH3{}+{\overset {sodium\ borohydride}{NaBH4}}{}+4H2O->4{\overset {1-Phenylethanol}{C6H5CH(OH)CH3}}{}+{\overset {sodium\ hydroxide}{NaOH}}{}+{\overset {boric\ acid}{B(OH)3}}->C6H5CH=CH2}}}


company (established in July 2000)

High Purity 142217-69-4 Entecavir HepavitalHigh Purity 142217-69-4 Entecavir HepavitalHigh Purity 142217-69-4 Entecavir HepavitalHigh Purity 142217-69-4 Entecavir HepavitalHigh Purity 142217-69-4 Entecavir HepavitalHigh Purity 142217-69-4 Entecavir Hepavital
 
Ensure employees have healthy diet, strengthen physical exercise, provide mental health help, provide employees with a high-quality rest environment, and provide the best protection for employees of large enterprises
High Purity 142217-69-4 Entecavir Hepavital












 

 

الكيماويات الصيدلانية

JCTK.CO.UK, 2023